Advertisement

Reactions Weekly

, Volume 1697, Issue 1, pp 300–300 | Cite as

Nivolumab

Infusion reaction and first report of neuromyelitis optica spectrum disorder: case report
Case report

Reference

  1. Narumi Y, et al. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report. BMC Cancer 18: 95, No. 1, 24 Jan 2018. Available from: URL: http://doi.org/10.1186/s12885-018-3997-2 -JapanCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations